Published in Eur J Hum Genet on March 01, 2001
Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology (2008) 3.74
Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am J Hum Genet (2002) 1.42
Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. J Med Genet (2003) 1.40
Macrocephalic mental retardation associated with a novel C-terminal MECP2 frameshift deletion. Eur J Pediatr (2004) 1.39
Rett syndrome: the complex nature of a monogenic disease. J Mol Med (Berl) (2003) 1.10
Very mild cases of Rett syndrome with skewed X inactivation. J Med Genet (2006) 0.95
A novel hypomorphic MECP2 point mutation is associated with a neuropsychiatric phenotype. Hum Genet (2008) 0.90
Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations. Orphanet J Rare Dis (2011) 0.78
The UCSC Genome Browser Database. Nucleic Acids Res (2003) 32.84
Regulation of tumor antigen synthesis by simain virus 40 gene A. J Virol (1975) 9.93
Positive control of transcription initiation in bacteria. Annu Rev Genet (1984) 8.74
Isolation of the bacteriophage lambda receptor from Escherichia coli. J Bacteriol (1973) 7.67
Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell (1994) 7.39
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature (1995) 7.11
Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature (1999) 6.42
Location of the maltose A and B loci on the genetic map of Escherichia coli. J Bacteriol (1966) 5.97
Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med (2001) 5.48
Maltose transport in Escherichia coli K12. A comparison of transport kinetics in wild-type and lambda-resistant mutants as measured by fluorescence quenching. Eur J Biochem (1976) 5.25
A role for mRNA secondary structure in the control of translation initiation. Nature (1982) 5.01
BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene (1998) 4.88
Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med (1991) 4.61
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta (1991) 4.16
Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat Genet (1994) 4.04
Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome. Cell (1991) 3.98
Use of gene fusions to study outer membrane protein localization in Escherichia coli. Proc Natl Acad Sci U S A (1977) 3.78
The adsorption of coliphage lambda to its host: effect of variations in the surface density of receptor and in phage-receptor affinity. J Mol Biol (1976) 3.75
Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet (1993) 3.63
Genetic analysis of the maltose A region in Escherichia coli. J Bacteriol (1969) 3.52
Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab (2001) 3.51
Escherichia coli mutants impaired in maltodextrin transport. J Bacteriol (1979) 3.51
Dominant constitutive mutations in malT, the positive regulator gene of the maltose regulon in Escherichia coli. J Mol Biol (1978) 3.46
Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation. Lancet (1991) 3.37
[Existence in Escherichia coli K 12 of a common regulation of the biosynthesis of bacteriophage receptors and maltose metabolism]. Ann Inst Pasteur (Paris) (1967) 3.33
Pleiotropic mutations rendering Escherichia coli K-12 resistant to bacteriophage TP1. J Bacteriol (1980) 3.31
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med (1999) 3.13
Patterns of polymorphism and linkage disequilibrium for cystic fibrosis. Genomics (1987) 3.03
Coronary artery bypass grafting: the Society of Thoracic Surgeons National Database experience. Ann Thorac Surg (1994) 3.00
Structure of the malB region in Escherichia coli K12. I. Genetic map of the malK-lamB operon. Mol Gen Genet (1979) 2.99
[Phenotypic expression and genetic localization of mutations affecting maltose metabolism in Escherichia coli K 12]. Ann Inst Pasteur (Paris) (1967) 2.83
Structure of the malB region in Escherichia coli K12. II. Genetic map of the malE,F,G operon. Mol Gen Genet (1979) 2.83
Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet (2001) 2.70
Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J Biol Chem (1997) 2.69
Complementation studies in the maltose-A region of the Escherichia coli K12 genetic map. J Mol Biol (1971) 2.60
malB region in Escherichia coli K-12: characterization of new mutations. J Bacteriol (1974) 2.56
CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet (2001) 2.51
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer. J Clin Oncol (1993) 2.49
Intergration of the receptor for bacteriophage lambda in the outer membrane of Escherichia coli: coupling with cell division. J Bacteriol (1975) 2.47
Mutations that affect lamB gene expression at a posttranscriptional level. Proc Natl Acad Sci U S A (1981) 2.46
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Mutations altering the cellular localization of the phage lambda receptor, an Escherichia coli outer membrane protein. Proc Natl Acad Sci U S A (1978) 2.37
Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res (2000) 2.36
Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics. Hum Genet (1990) 2.33
Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med (1998) 2.31
Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet (1994) 2.31
The use of gene fusions to study the expression of malT the positive regulator gene of the maltose regulon. J Mol Biol (1979) 2.27
Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest (1999) 2.24
Control of expression of the pyr genes in Salmonella typhimurium: effects of variations in uridine and cytidine nucleotide pools. J Bacteriol (1975) 2.24
[Maltodextrin phosphorylase of Escherichia coli]. Eur J Biochem (1967) 2.21
Sequence information within the lamB genes in required for proper routing of the bacteriophage lambda receptor protein to the outer membrane of Escherichia coli K-12. J Mol Biol (1982) 2.20
A technique for integrating any DNA fragment into the chromosome of Escherichia coli. Gene (1984) 2.11
Phosphoglucomutase mutants of Escherichia coli K-12. J Bacteriol (1971) 2.07
The enigma of myelin-associated growth inhibitors in spontaneously regenerating nervous systems. Trends Neurosci (1994) 2.06
Protein Ia and the lamB protein can replace each other in the constitution of an active receptor for the same coliphage. Proc Natl Acad Sci U S A (1978) 2.06
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer. Ann Oncol (2007) 2.03
Colicin E2 release: lysis, leakage or secretion? Possible role of a phospholipase. EMBO J (1984) 2.02
Extracellular pullulanase of Klebsiella pneumoniae is a lipoprotein. J Bacteriol (1986) 2.02
A signal sequence is not sufficient to lead beta-galactosidase out of the cytoplasm. Nature (1980) 2.00
Induction of enzymes involed in the catabolism of deoxyribonucleosides and ribonucleosides in Escherichia coli K 12. Eur J Biochem (1971) 1.97
Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med (1998) 1.93
Mutations allowing growth on maltose of Escherichia coli K 12 strains with a deleted malT gene. Mol Gen Genet (1971) 1.92
Molecular characterization of a novel human hybrid-type receptor that binds the alpha2-macroglobulin receptor-associated protein. J Biol Chem (1996) 1.90
Systematic review of the treatment and prognosis of the odontogenic keratocyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.85
Impact of internal mammary artery conduits on operative mortality in coronary revascularization. Ann Thorac Surg (1994) 1.85
Alcohol dehydrogenase-negative mutants in Drosophila: defects at the structural locus? Genetics (1976) 1.84
On the significance of the retention of ligand by protein. Proc Natl Acad Sci U S A (1975) 1.83
Energy-coupling of the transport system of Escherichia coli dependent on maltose-binding protein. Eur J Biochem (1977) 1.83
Reversible interaction between coliphage lambda and its receptor protein. J Mol Biol (1975) 1.82
Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat (1993) 1.79
Characterization and expression of the structural gene for pullulanase, a maltose-inducible secreted protein of Klebsiella pneumoniae. J Bacteriol (1985) 1.78
Restriction map of the Escherichia coli malA region and identification of the malT product. J Bacteriol (1980) 1.77
Fractures of the spine in diffuse idiopathic skeletal hyperostosis. Clin Orthop Relat Res (1991) 1.76
Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta (1991) 1.75
Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA (1991) 1.75
Occurrence of the bacteriophage lambda receptor in some enterobacteriaceae. J Virol (1975) 1.74
Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene. Hum Mutat (1997) 1.74
Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut (2005) 1.72
Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med (1996) 1.72
Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics (1993) 1.71
Characterization of Erwinia chrysanthemi extracellular proteases: cloning and expression of the protease genes in Escherichia coli. J Bacteriol (1987) 1.71
Linkage mapping in 29 Bardet-Biedl syndrome families confirms loci in chromosomal regions 11q13, 15q22.3-q23, and 16q21. Genomics (1997) 1.70
Magnetic resonance image-directed stereotactic neurosurgery: use of image fusion with computerized tomography to enhance spatial accuracy. J Neurosurg (1995) 1.70
Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry (2011) 1.69
In vivo assessment of mutations in the phenylalanine hydroxylase gene by phenylalanine loading: characterization of seven common mutations. Eur J Pediatr (1995) 1.69
The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet (1998) 1.67
Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol (1977) 1.66
Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64
Understanding physicians' intentions to withdraw from practice: the role of job satisfaction, job stress, mental and physical health. Health Care Manage Rev (2001) 1.63
Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel. Am J Physiol (1998) 1.63
Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci (2000) 1.62
Repression of transcriptional activity by heterologous KRAB domains present in zinc finger proteins. FEBS Lett (1995) 1.62
Uridine phosphorylase from Escherichia coli. Physical and chemical characterization. Eur J Biochem (1977) 1.61
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A (2000) 1.61
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci U S A (2001) 1.61
Inflammation after axonal injury has conflicting consequences for recovery of function: rescue of spared axons is impaired but regeneration is supported. J Neuroimmunol (1994) 1.60
Bicalutamide for advanced prostate cancer: the natural versus treated history of disease. J Clin Oncol (1997) 1.60
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
The effect of nalidixic acid on the expression of some genes in Escherichia coli K-12. Biochem Biophys Res Commun (1975) 1.59